[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Oxaliplatin Market - Global Outlook and Forecast 2021-2027

March 2021 | 114 pages | ID: OC86DB51AC15EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Oxaliplatin in Global, including the following market information:

Global Oxaliplatin Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Oxaliplatin market was valued at 905.4 million in 2020 and is projected to reach US$ 1253.8 million by 2027, at a CAGR of 8.5% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oxaliplatin companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Oxaliplatin Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Oxaliplatin Market Segment Percentages, By Type, 2020 (%)
  • Mannitol
  • Glucose Solution
  • Lactose Solution
  • Others
China Oxaliplatin Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Oxaliplatin Market Segment Percentages, By Application, 2020 (%)
  • Colorectal Cancer
  • Stomach Cancer
  • Ovarian Cancer
  • Others
Global Oxaliplatin Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Oxaliplatin Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Oxaliplatin Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Oxaliplatin Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • Sanofi-Aventis
  • Yakult honsha
  • Dr Reddy's laboratories
  • Sun Pharmaceutical
  • Teva
  • Fresenius Kabi
  • Hospira
  • Mylan
  • Jiangsu Hengrui Medicine
  • Nanjing Pharmaceutical Factory
  • Jiangsu Aosaikang Pharmaceutical
  • Qilu Pharmaceutical
  • Hisun Pharmaceutical
  • Lunan Pharmaceutical
  • Luoxin
  • Halfsky Pharmacy
  • YRPG
  • Hainan Jinrui Pharmaceutical
  • Jari Pharmaceutical
  • Chiatai Tianqing
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Oxaliplatin Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Oxaliplatin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL OXALIPLATIN OVERALL MARKET SIZE

2.1 Global Oxaliplatin Market Size: 2021 VS 2027
2.2 Global Oxaliplatin Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Oxaliplatin Players in Global Market
3.2 Top Global Oxaliplatin Companies Ranked by Revenue
3.3 Global Oxaliplatin Revenue by Companies
3.4 Top 3 and Top 5 Oxaliplatin Companies in Global Market, by Revenue in 2020
3.5 Global Companies Oxaliplatin Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oxaliplatin Players in Global Market
  3.6.1 List of Global Tier 1 Oxaliplatin Companies
  3.6.2 List of Global Tier 2 and Tier 3 Oxaliplatin Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Oxaliplatin Market Size Markets, 2021 & 2027
  4.1.2 Mannitol
  4.1.3 Glucose Solution
  4.1.4 Lactose Solution
  4.1.5 Others
4.2 By Type - Global Oxaliplatin Revenue & Forecasts
  4.2.1 By Type - Global Oxaliplatin Revenue, 2016-2021
  4.2.2 By Type - Global Oxaliplatin Revenue, 2022-2027
  4.2.3 By Type - Global Oxaliplatin Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Oxaliplatin Market Size, 2021 & 2027
  5.1.2 Colorectal Cancer
  5.1.3 Stomach Cancer
  5.1.4 Ovarian Cancer
  5.1.5 Others
5.2 By Application - Global Oxaliplatin Revenue & Forecasts
  5.2.1 By Application - Global Oxaliplatin Revenue, 2016-2021
  5.2.2 By Application - Global Oxaliplatin Revenue, 2022-2027
  5.2.3 By Application - Global Oxaliplatin Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Oxaliplatin Market Size, 2021 & 2027
6.2 By Region - Global Oxaliplatin Revenue & Forecasts
  6.2.1 By Region - Global Oxaliplatin Revenue, 2016-2021
  6.2.2 By Region - Global Oxaliplatin Revenue, 2022-2027
  6.2.3 By Region - Global Oxaliplatin Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Oxaliplatin Revenue, 2016-2027
  6.3.2 US Oxaliplatin Market Size, 2016-2027
  6.3.3 Canada Oxaliplatin Market Size, 2016-2027
  6.3.4 Mexico Oxaliplatin Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Oxaliplatin Revenue, 2016-2027
  6.4.2 Germany Oxaliplatin Market Size, 2016-2027
  6.4.3 France Oxaliplatin Market Size, 2016-2027
  6.4.4 U.K. Oxaliplatin Market Size, 2016-2027
  6.4.5 Italy Oxaliplatin Market Size, 2016-2027
  6.4.6 Russia Oxaliplatin Market Size, 2016-2027
  6.4.7 Nordic Countries Oxaliplatin Market Size, 2016-2027
  6.4.8 Benelux Oxaliplatin Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Oxaliplatin Revenue, 2016-2027
  6.5.2 China Oxaliplatin Market Size, 2016-2027
  6.5.3 Japan Oxaliplatin Market Size, 2016-2027
  6.5.4 South Korea Oxaliplatin Market Size, 2016-2027
  6.5.5 Southeast Asia Oxaliplatin Market Size, 2016-2027
  6.5.6 India Oxaliplatin Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Oxaliplatin Revenue, 2016-2027
  6.6.2 Brazil Oxaliplatin Market Size, 2016-2027
  6.6.3 Argentina Oxaliplatin Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Oxaliplatin Revenue, 2016-2027
  6.7.2 Turkey Oxaliplatin Market Size, 2016-2027
  6.7.3 Israel Oxaliplatin Market Size, 2016-2027
  6.7.4 Saudi Arabia Oxaliplatin Market Size, 2016-2027
  6.7.5 UAE Oxaliplatin Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Sanofi-Aventis
  7.1.1 Sanofi-Aventis Corporate Summary
  7.1.2 Sanofi-Aventis Business Overview
  7.1.3 Sanofi-Aventis Oxaliplatin Major Product Offerings
  7.1.4 Sanofi-Aventis Oxaliplatin Revenue in Global (2016-2021)
  7.1.5 Sanofi-Aventis Key News
7.2 Yakult honsha
  7.2.1 Yakult honsha Corporate Summary
  7.2.2 Yakult honsha Business Overview
  7.2.3 Yakult honsha Oxaliplatin Major Product Offerings
  7.2.4 Yakult honsha Oxaliplatin Revenue in Global (2016-2021)
  7.2.5 Yakult honsha Key News
7.3 Dr Reddy's laboratories
  7.3.1 Dr Reddy's laboratories Corporate Summary
  7.3.2 Dr Reddy's laboratories Business Overview
  7.3.3 Dr Reddy's laboratories Oxaliplatin Major Product Offerings
  7.3.4 Dr Reddy's laboratories Oxaliplatin Revenue in Global (2016-2021)
  7.3.5 Dr Reddy's laboratories Key News
7.4 Sun Pharmaceutical
  7.4.1 Sun Pharmaceutical Corporate Summary
  7.4.2 Sun Pharmaceutical Business Overview
  7.4.3 Sun Pharmaceutical Oxaliplatin Major Product Offerings
  7.4.4 Sun Pharmaceutical Oxaliplatin Revenue in Global (2016-2021)
  7.4.5 Sun Pharmaceutical Key News
7.5 Teva
  7.5.1 Teva Corporate Summary
  7.5.2 Teva Business Overview
  7.5.3 Teva Oxaliplatin Major Product Offerings
  7.5.4 Teva Oxaliplatin Revenue in Global (2016-2021)
  7.5.5 Teva Key News
7.6 Fresenius Kabi
  7.6.1 Fresenius Kabi Corporate Summary
  7.6.2 Fresenius Kabi Business Overview
  7.6.3 Fresenius Kabi Oxaliplatin Major Product Offerings
  7.6.4 Fresenius Kabi Oxaliplatin Revenue in Global (2016-2021)
  7.6.5 Fresenius Kabi Key News
7.7 Hospira
  7.7.1 Hospira Corporate Summary
  7.7.2 Hospira Business Overview
  7.7.3 Hospira Oxaliplatin Major Product Offerings
  7.4.4 Hospira Oxaliplatin Revenue in Global (2016-2021)
  7.7.5 Hospira Key News
7.8 Mylan
  7.8.1 Mylan Corporate Summary
  7.8.2 Mylan Business Overview
  7.8.3 Mylan Oxaliplatin Major Product Offerings
  7.8.4 Mylan Oxaliplatin Revenue in Global (2016-2021)
  7.8.5 Mylan Key News
7.9 Jiangsu Hengrui Medicine
  7.9.1 Jiangsu Hengrui Medicine Corporate Summary
  7.9.2 Jiangsu Hengrui Medicine Business Overview
  7.9.3 Jiangsu Hengrui Medicine Oxaliplatin Major Product Offerings
  7.9.4 Jiangsu Hengrui Medicine Oxaliplatin Revenue in Global (2016-2021)
  7.9.5 Jiangsu Hengrui Medicine Key News
7.10 Nanjing Pharmaceutical Factory
  7.10.1 Nanjing Pharmaceutical Factory Corporate Summary
  7.10.2 Nanjing Pharmaceutical Factory Business Overview
  7.10.3 Nanjing Pharmaceutical Factory Oxaliplatin Major Product Offerings
  7.10.4 Nanjing Pharmaceutical Factory Oxaliplatin Revenue in Global (2016-2021)
  7.10.5 Nanjing Pharmaceutical Factory Key News
7.11 Jiangsu Aosaikang Pharmaceutical
  7.11.1 Jiangsu Aosaikang Pharmaceutical Corporate Summary
  7.11.2 Jiangsu Aosaikang Pharmaceutical Business Overview
  7.11.3 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Major Product Offerings
  7.11.4 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Revenue in Global (2016-2021)
  7.11.5 Jiangsu Aosaikang Pharmaceutical Key News
7.12 Qilu Pharmaceutical
  7.12.1 Qilu Pharmaceutical Corporate Summary
  7.12.2 Qilu Pharmaceutical Business Overview
  7.12.3 Qilu Pharmaceutical Oxaliplatin Major Product Offerings
  7.12.4 Qilu Pharmaceutical Oxaliplatin Revenue in Global (2016-2021)
  7.12.5 Qilu Pharmaceutical Key News
7.13 Hisun Pharmaceutical
  7.13.1 Hisun Pharmaceutical Corporate Summary
  7.13.2 Hisun Pharmaceutical Business Overview
  7.13.3 Hisun Pharmaceutical Oxaliplatin Major Product Offerings
  7.13.4 Hisun Pharmaceutical Oxaliplatin Revenue in Global (2016-2021)
  7.13.5 Hisun Pharmaceutical Key News
7.14 Lunan Pharmaceutical
  7.14.1 Lunan Pharmaceutical Corporate Summary
  7.14.2 Lunan Pharmaceutical Business Overview
  7.14.3 Lunan Pharmaceutical Oxaliplatin Major Product Offerings
  7.14.4 Lunan Pharmaceutical Oxaliplatin Revenue in Global (2016-2021)
  7.14.5 Lunan Pharmaceutical Key News
7.15 Luoxin
  7.15.1 Luoxin Corporate Summary
  7.15.2 Luoxin Business Overview
  7.15.3 Luoxin Oxaliplatin Major Product Offerings
  7.15.4 Luoxin Oxaliplatin Revenue in Global (2016-2021)
  7.15.5 Luoxin Key News
7.16 Halfsky Pharmacy
  7.16.1 Halfsky Pharmacy Corporate Summary
  7.16.2 Halfsky Pharmacy Business Overview
  7.16.3 Halfsky Pharmacy Oxaliplatin Major Product Offerings
  7.16.4 Halfsky Pharmacy Oxaliplatin Revenue in Global (2016-2021)
  7.16.5 Halfsky Pharmacy Key News
7.17 YRPG
  7.17.1 YRPG Corporate Summary
  7.17.2 YRPG Business Overview
  7.17.3 YRPG Oxaliplatin Major Product Offerings
  7.17.4 YRPG Oxaliplatin Revenue in Global (2016-2021)
  7.17.5 YRPG Key News
7.18 Hainan Jinrui Pharmaceutical
  7.18.1 Hainan Jinrui Pharmaceutical Corporate Summary
  7.18.2 Hainan Jinrui Pharmaceutical Business Overview
  7.18.3 Hainan Jinrui Pharmaceutical Oxaliplatin Major Product Offerings
  7.18.4 Hainan Jinrui Pharmaceutical Oxaliplatin Revenue in Global (2016-2021)
  7.18.5 Hainan Jinrui Pharmaceutical Key News
7.19 Jari Pharmaceutical
  7.19.1 Jari Pharmaceutical Corporate Summary
  7.19.2 Jari Pharmaceutical Business Overview
  7.19.3 Jari Pharmaceutical Oxaliplatin Major Product Offerings
  7.19.4 Jari Pharmaceutical Oxaliplatin Revenue in Global (2016-2021)
  7.19.5 Jari Pharmaceutical Key News
7.20 Chiatai Tianqing
  7.20.1 Chiatai Tianqing Corporate Summary
  7.20.2 Chiatai Tianqing Business Overview
  7.20.3 Chiatai Tianqing Oxaliplatin Major Product Offerings
  7.20.4 Chiatai Tianqing Oxaliplatin Revenue in Global (2016-2021)
  7.20.5 Chiatai Tianqing Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Oxaliplatin Market Opportunities & Trends in Global Market
Table 2. Oxaliplatin Market Drivers in Global Market
Table 3. Oxaliplatin Market Restraints in Global Market
Table 4. Key Players of Oxaliplatin in Global Market
Table 5. Top Oxaliplatin Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Oxaliplatin Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Oxaliplatin Revenue Share by Companies, 2016-2021
Table 8. Global Companies Oxaliplatin Product Type
Table 9. List of Global Tier 1 Oxaliplatin Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oxaliplatin Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Oxaliplatin Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Oxaliplatin Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Oxaliplatin Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Oxaliplatin Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Oxaliplatin Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Oxaliplatin Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Oxaliplatin Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Oxaliplatin Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Oxaliplatin Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Oxaliplatin Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Oxaliplatin Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Oxaliplatin Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Oxaliplatin Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Oxaliplatin Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Oxaliplatin Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Oxaliplatin Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Oxaliplatin Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Oxaliplatin Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Oxaliplatin Revenue, (US$, Mn), 2022-2027
Table 30. Sanofi-Aventis Corporate Summary
Table 31. Sanofi-Aventis Oxaliplatin Product Offerings
Table 32. Sanofi-Aventis Oxaliplatin Revenue (US$, Mn), (2016-2021)
Table 33. Yakult honsha Corporate Summary
Table 34. Yakult honsha Oxaliplatin Product Offerings
Table 35. Yakult honsha Oxaliplatin Revenue (US$, Mn), (2016-2021)
Table 36. Dr Reddy's laboratories Corporate Summary
Table 37. Dr Reddy's laboratories Oxaliplatin Product Offerings
Table 38. Dr Reddy's laboratories Oxaliplatin Revenue (US$, Mn), (2016-2021)
Table 39. Sun Pharmaceutical Corporate Summary
Table 40. Sun Pharmaceutical Oxaliplatin Product Offerings
Table 41. Sun Pharmaceutical Oxaliplatin Revenue (US$, Mn), (2016-2021)
Table 42. Teva Corporate Summary
Table 43. Teva Oxaliplatin Product Offerings
Table 44. Teva Oxaliplatin Revenue (US$, Mn), (2016-2021)
Table 45. Fresenius Kabi Corporate Summary
Table 46. Fresenius Kabi Oxaliplatin Product Offerings
Table 47. Fresenius Kabi Oxaliplatin Revenue (US$, Mn), (2016-2021)
Table 48. Hospira Corporate Summary
Table 49. Hospira Oxaliplatin Product Offerings
Table 50. Hospira Oxaliplatin Revenue (US$, Mn), (2016-2021)
Table 51. Mylan Corporate Summary
Table 52. Mylan Oxaliplatin Product Offerings
Table 53. Mylan Oxaliplatin Revenue (US$, Mn), (2016-2021)
Table 54. Jiangsu Hengrui Medicine Corporate Summary
Table 55. Jiangsu Hengrui Medicine Oxaliplatin Product Offerings
Table 56. Jiangsu Hengrui Medicine Oxaliplatin Revenue (US$, Mn), (2016-2021)
Table 57. Nanjing Pharmaceutical Factory Corporate Summary
Table 58. Nanjing Pharmaceutical Factory Oxaliplatin Product Offerings
Table 59. Nanjing Pharmaceutical Factory Oxaliplatin Revenue (US$, Mn), (2016-2021)
Table 60. Jiangsu Aosaikang Pharmaceutical Corporate Summary
Table 61. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Product Offerings
Table 62. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Revenue (US$, Mn), (2016-2021)
Table 63. Qilu Pharmaceutical Corporate Summary
Table 64. Qilu Pharmaceutical Oxaliplatin Product Offerings
Table 65. Qilu Pharmaceutical Oxaliplatin Revenue (US$, Mn), (2016-2021)
Table 66. Hisun Pharmaceutical Corporate Summary
Table 67. Hisun Pharmaceutical Oxaliplatin Product Offerings
Table 68. Hisun Pharmaceutical Oxaliplatin Revenue (US$, Mn), (2016-2021)
Table 69. Lunan Pharmaceutical Corporate Summary
Table 70. Lunan Pharmaceutical Oxaliplatin Product Offerings
Table 71. Lunan Pharmaceutical Oxaliplatin Revenue (US$, Mn), (2016-2021)
Table 72. Luoxin Corporate Summary
Table 73. Luoxin Oxaliplatin Product Offerings
Table 74. Luoxin Oxaliplatin Revenue (US$, Mn), (2016-2021)
Table 75. Halfsky Pharmacy Corporate Summary
Table 76. Halfsky Pharmacy Oxaliplatin Product Offerings
Table 77. Halfsky Pharmacy Oxaliplatin Revenue (US$, Mn), (2016-2021)
Table 78. YRPG Corporate Summary
Table 79. YRPG Oxaliplatin Product Offerings
Table 80. YRPG Oxaliplatin Revenue (US$, Mn), (2016-2021)
Table 81. Hainan Jinrui Pharmaceutical Corporate Summary
Table 82. Hainan Jinrui Pharmaceutical Oxaliplatin Product Offerings
Table 83. Hainan Jinrui Pharmaceutical Oxaliplatin Revenue (US$, Mn), (2016-2021)
Table 84. Jari Pharmaceutical Corporate Summary
Table 85. Jari Pharmaceutical Oxaliplatin Product Offerings
Table 86. Jari Pharmaceutical Oxaliplatin Revenue (US$, Mn), (2016-2021)
Table 87. Chiatai Tianqing Corporate Summary
Table 88. Chiatai Tianqing Oxaliplatin Product Offerings
Table 89. Chiatai Tianqing Oxaliplatin Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. Oxaliplatin Segment by Type
Figure 2. Oxaliplatin Segment by Application
Figure 3. Global Oxaliplatin Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Oxaliplatin Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Oxaliplatin Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Oxaliplatin Revenue in 2020
Figure 8. By Type - Global Oxaliplatin Revenue Market Share, 2016-2027
Figure 9. By Application - Global Oxaliplatin Revenue Market Share, 2016-2027
Figure 10. By Region - Global Oxaliplatin Revenue Market Share, 2016-2027
Figure 11. By Country - North America Oxaliplatin Revenue Market Share, 2016-2027
Figure 12. US Oxaliplatin Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Oxaliplatin Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Oxaliplatin Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Oxaliplatin Revenue Market Share, 2016-2027
Figure 16. Germany Oxaliplatin Revenue, (US$, Mn), 2016-2027
Figure 17. France Oxaliplatin Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Oxaliplatin Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Oxaliplatin Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Oxaliplatin Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Oxaliplatin Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Oxaliplatin Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Oxaliplatin Revenue Market Share, 2016-2027
Figure 24. China Oxaliplatin Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Oxaliplatin Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Oxaliplatin Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Oxaliplatin Revenue, (US$, Mn), 2016-2027
Figure 28. India Oxaliplatin Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Oxaliplatin Revenue Market Share, 2016-2027
Figure 30. Brazil Oxaliplatin Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Oxaliplatin Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Oxaliplatin Revenue Market Share, 2016-2027
Figure 33. Turkey Oxaliplatin Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Oxaliplatin Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Oxaliplatin Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Oxaliplatin Revenue, (US$, Mn), 2016-2027
Figure 37. Sanofi-Aventis Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Yakult honsha Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Dr Reddy's laboratories Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Sun Pharmaceutical Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Teva Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Fresenius Kabi Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Hospira Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Mylan Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Jiangsu Hengrui Medicine Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Nanjing Pharmaceutical Factory Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Qilu Pharmaceutical Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Hisun Pharmaceutical Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Lunan Pharmaceutical Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Luoxin Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Halfsky Pharmacy Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 53. YRPG Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 54. Hainan Jinrui Pharmaceutical Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 55. Jari Pharmaceutical Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 56. Chiatai Tianqing Oxaliplatin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications